Blog · JUL 19, 2026 · 3 min read
Connex at Scale: What a Year of Pilots Taught Us
A year of Connex pilots taught us that verifying a meeting happened is harder than scheduling it in the first place.
A year ago, Connex was three hospitals and a handful of pharma teams willing to test a new way of scheduling doctor meetings. Today it is running across a meaningfully larger footprint, with pilots converting into ongoing paid relationships rather than staying pilots indefinitely. Here is what that year actually taught us.
The free-for-doctors bet paid off
We built Connex so doctors never pay anything, in person or virtual, ever. Pharma pays only per verified visit. This was a deliberate bet that removing all friction and cost on the doctor side would drive adoption faster than any feature we could build. It was the single biggest factor in getting doctors to actually use the system instead of treating it as one more scheduling tool competing with a phone call.
Verification was the harder half
Scheduling a meeting turned out to be the easy engineering problem. Verifying that a meeting actually happened, in a way both the doctor and the pharma company would trust and that would hold up as the basis for payment, took far longer to get right than the calendar and notification layer around it.
We iterated through several verification approaches before landing on one that pharma finance teams were comfortable auditing and doctors did not experience as intrusive.
What pilots taught us about growth
- •Hospitals that saw early value converted from pilot to paid faster when a single administrator championed the rollout internally, rather than when the push came only from pharma
- •Virtual meetings grew faster than in-person ones once doctors experienced how little setup they required
- •Pharma teams asked for reporting and verification detail well beyond what we originally scoped, and building that out properly is what turned pilots into renewals
Where this leaves us
Connex is no longer the experimental product in the family. It has become mature enough, and trusted enough by hospitals, to be the foundation PatientVoice was built on top of. That is not a small milestone. It means the structured, verified engagement model we bet on a year ago is now solid enough to carry a second product on its back, and we expect it to carry more.